The University of New Mexico Departments of Neurology and Internal Medicine, Division of Hematology/Oncology, and the University of New Mexico Comprehensive Cancer Center (UNMCCC) invite applications from physicians or physician scientists with training and expertise in neuro-oncology and a focused interest in clinical care and clinical research for patients with cancers of the brain and spinal cord. The successful applicant will participate in the multidisciplinary clinical care of patients and in the design and conduct of cancer clinical trials and clinical interventions as a member or co-leader of the Multidisciplinary Working Group in Neuro-Oncology. This is an Open Rank, Open Track position. Leadership opportunities exist for outstanding candidates with a strong track-record of accomplishments, program-building experience and a history of collaboration across multiple departments. Faculty rank and appointment will be commensurate with training and accomplishments. The successful applicant will be Board certified in Neurology with UCNS certification in Neuro-oncology with experience in the clinical care of patients with neurological cancers and strong interest in the development of clinical trials and novel targeted therapies. Emphasis is placed on the ability to foster interaction between laboratory and clinical investigators, participate in multidisciplinary clinical trial teams, and participate in the teaching mission of the Departments, Division, the Cancer Center, and the Institution. Excellent compensation and start up packages are available to support the research activities of the candidate.
The University of New Mexico Comprehensive Cancer Center (UNMCCC) is the Official Cancer Center of New Mexico and the only National Cancer Institute (NCI) Designated Comprehensive Cancer Center within a 500-mile radius. The 143 oncology physicians and surgeons, 135 cancer research scientists, and over 600 staff are particularly focused on discovering the causes and the cures for cancers that disproportionately affect the people of the American Southwest – primarily Hispanic, American Indian, and Non-Hispanic White – with strikingly different patterns of cancer incidence, mortality and disparity. The Center treated over 12,800 unique patients in FY19, 13% of whom participated in therapeutic interventional studies and 35% of whom participated in interventional studies. The UNMCCC has outstanding research programs in Cancer Control and Population Sciences; Cancer Cellular and Molecular Oncology (Cancer Genetics, Epigenetics, and Genomics and Cancer Cell and Systems Biology); and Cancer Therapeutics. These programs house several national centers including: The Molecular Discovery and High Throughput Target Screening Center (nmmlsc.health.unm.edu), one of the nation’s 6 Chemical Biology Consortium Centers of Excellence in The NCI NExT Program; The New Mexico Center for the Spatiotemporal Modeling of Cell Signaling (stmc.health.unm.edu), one of 13 NIH National Centers for Systems Biology; and a NIH Clinical and Translational Sciences Center. Rich collaborations with UNMCCC partners (Sandia and Los Alamos National Laboratories; Lovelace Respiratory Research Institute) with unparalleled computing and technology infrastructure enrich our research endeavors. The UNMCCC is the center of a collaborative statewide cancer clinical trials and health delivery research network and is funded by a NCI NCORP Grant (Minority/Underserved), and is also a member of the ORIEN National Cancer Precision Medicine Network (http://oriencancer.org/). Center members have conducted more than 60 statewide community-based cancer education, prevention, screening, and behavioral intervention studies involving more than 10,000 New Mexicans. Learn more at http://cancer.unm.edu/.
The University of New Mexico is committed to hiring and retaining a diverse workforce. We are an Equal Opportunity Employer, making decisions without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, age, veteran status, disability, or any other protected class.